SSTR2 and neoplasm: We measured, on average, a slight increasein tumor uptake with MMC(FNIR-Tag)-TOC and a >60% signal reductionin tumors lacking SSTR2 and in most nontarget tissues, including thoseassociated with NET surgery (e.g., pancreas, small intestine) (Figure 2C).